However, the APCs at the tumor microenvironment are frequently immunosuppressive and lead to unresponsiveness of T cells4, which may restrict the activation of CD4+ T cells and therefore limit the provision of CD4-help at the tumor microenvironment. This evidence concerns the gene CD4 and neoplasm.